LUCCHESI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 303
EU - Europa 229
AS - Asia 68
AF - Africa 28
OC - Oceania 1
SA - Sud America 1
Totale 630
Nazione #
US - Stati Uniti d'America 303
SE - Svezia 85
GB - Regno Unito 76
IN - India 26
TG - Togo 24
DE - Germania 22
VN - Vietnam 21
IT - Italia 19
CN - Cina 18
FR - Francia 9
RU - Federazione Russa 8
EE - Estonia 4
ZA - Sudafrica 4
FI - Finlandia 2
LB - Libano 2
AU - Australia 1
BE - Belgio 1
CL - Cile 1
MD - Moldavia 1
RO - Romania 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 630
Città #
Southend 73
Fairfield 42
Princeton 32
Woodbridge 25
Houston 24
Lomé 24
Ashburn 23
Chandler 20
Seattle 20
Cambridge 15
Ann Arbor 12
Wilmington 12
Berlin 10
Des Moines 9
San Diego 9
Nanjing 7
Westminster 6
Bologna 4
Falls Church 4
Padova 3
Saint Petersburg 3
Beijing 2
Chieti 2
Frankfurt am Main 2
Hebei 2
Jinan 2
Medford 2
Phoenix 2
Ashland 1
Bari 1
Brussels 1
Buffalo 1
Changsha 1
Chisinau 1
Fayetteville 1
Fremont 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Helsinki 1
Leeds 1
Ljubljana 1
Melbourne 1
Nanchang 1
North Bergen 1
Parma 1
Redmond 1
Rome 1
San Giuliano Milanese 1
Shenyang 1
Verona 1
Volla 1
Totale 415
Nome #
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients 93
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients 83
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. 82
null 76
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 61
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years. 32
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin? 30
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 29
Managing chronic myeloid leukemia for treatment-free remission: A proposal from the GIMEMA CML WP 24
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 24
Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations 23
Platelets beyond their count, as a key element of the innate immune system in the fight against malaria 22
Management of kidney transplantation in a factor VII-deficient patient: Case report 21
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: Results from the ITACa trial 20
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 18
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report 16
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools 11
IL-17/IL-10 double-producing T cells: New link between infections, immunosuppression and acute myeloid leukemia 6
Totale 671
Categoria #
all - tutte 1068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20185 0000 00 10 1030
2018/201921 0301 03 02 1524
2019/2020150 203012 1612 1922 249112
2020/202191 17430 14 56 561030
2021/2022282 722733 2124 122 17176843
2022/2023121 2874190 00 00 0000
Totale 671